Microscopic images of the various types of fat tissues developed in mice after transplantation. Top panels show the fat tissue’s general morphology, and the bottom panels are the tissue sections stained with hUCP1 (red color), which is unique for brown fat cells. These images show that while the HUMBLE fat cells are morphologically similar to the white fat cells, they express the brown fat specific hUCP1 protein. (Joslin Diabetes Center)
Studies in mice offer a proof of concept that ‘HUMBLE’ cells, created from human white fat, can treat metabolic diseases.
Obesity is the main cause of type 2 diabetes and related chronic illnesses that together will kill more people around the globe this year than the Covid-19 coronavirus. Scientists at Joslin Diabetes Center have delivered a proof of concept for a novel cell-based therapy against this dangerous condition.
The potential therapy for obesity would transplant HUMBLE (human brown-like) fat cells, human white fat cells that have been genetically modified to become similar to heat-generating brown fat cells, says Yu-Hua Tseng, PhD, a Senior Investigator in Joslin’s Section on Integrative Physiology and Metabolism.
Brown fat cells burn energy instead of storing energy as white fat cells do, says Tseng, senior author on a paper about the work in Science Translational Medicine . In the process, brown fat can lower excessive levels of glucose and lipids in the blood that are linked to metabolic diseases such as diabetes.
However, people who are overweight or obese tend to have less of this beneficial brown fat—a barrier that HUMBLE cells are designed to overcome, Tseng says.
She and her colleagues created the cells from human white fat cells in a progenitor stage (not yet fully developed into their final fat form). The investigators used a variant of the CRISPR-Cas9 genome editing system to boost expression of a gene called UCP1, which triggers white fat cell progenitors to develop into brown fat-like cells.
Transplanted into mice lacking an immune system, the HUMBLE progenitor cells developed into cells that functioned very much like the mice’s own brown fat cells, says Tseng, who is also a professor of medicine at Harvard Medical School.
Her team compared transplants of these cells versus the original white fat cells in mice who were put on a high fat diet. Mice given the HUMBLE transplants displayed much greater sensitivity to insulin and ability to clear glucose from the blood (two key factors that are impaired in type 2 diabetes).
Additionally, the mice receiving HUMBLE transplants put on less weight than mice with transplanted white fat cells, remaining in the same range as animals who received brown fat cells.
Perhaps surprisingly, the Joslin scientists demonstrated that these benefits were mostly due to signals from the transplanted cells to endogenous (existing) brown fat cells in the mice. “Cells in different tissues communicate with each other,” Tseng says. “In this case, we found that our transplanted HUMBLE cells secrete a molecule called nitric oxide, which is carried by red blood cells to the endogenous brown cells and activates those cells.”
If the HUMBLE technique continues to prove out in pre-clinical research, it might eventually be possible to generate this type of cell for individual patients, Tseng suggests. Such a procedure would remove a tiny amount of a patient’s white fat cells, isolate the progenitor cells, modify those cells to boost expression of UCP1, and then return the resulting HUMBLE cells to the patient.
However, that individualized approach would be complicated and expensive, so the Tseng lab is pursuing two alternative routes that may be more practical for clinical use.
One alternative is to use cells that are not personalized but instead are encapsulated via biomaterials that protect the cells from rejection by a patient’s immune system. (Joslin researchers and their collaborators have long studied such materials for cell transplants for type 1 diabetes.) The other option is gene therapies that directly express the UCP1 gene in white fat progenitor cells in the body, so that those cells acquire HUMBLE-like properties.
Tseng emphasizes that this research is moving ahead despite the Covid-19 pandemic, which puts people with diabetes at much higher risk of serious outcomes if they are infected.
“Employing cell-based or gene therapies to treat obesity or type 2 diabetes used to be science fiction,” she says. “Now scientific advances, such as CRISPR gene-editing technologies, will help us to improve the metabolism, the body weight, the quality of life and the overall health of people with obesity and diabetes.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- ‘Obesity should have been on comorbidity list’on February 28, 2021 at 1:09 pm
Overall, the categories of underlying conditions for vaccination released by the Union health ministry on Saturday has divided the medical community with some calling it exhaustive, while others have ...
- Obesity Care Week 2021 Aims to Change the Way We Care About Obesity through Awareness and Actionon February 28, 2021 at 11:16 am
Sunday, February 28th, marks the beginning of Obesity Care Week (OCW) 2021, an awareness campaign week aimed at changing the way we care about obesity by providing science and clinically-based ...
- Obesity Specialist Says BMI Is A 'Good Measure' For Vaccine Priority Groupon February 28, 2021 at 9:46 am
As cities offer vaccine appointments for people with a BMI of at least 30 — the medical benchmark for obesity — Dr. Fatima Stanford pushes back against the shame faced by those with the disease.
- Research identifies obesity and infection linkon February 26, 2021 at 9:33 am
The list of diseases and conditions complicated by obesity is a long one; it includes heart disease, cancer, diabetes and impaired wound healing, as well as skin infections. It is not always clear, ...
- Brazilian Patent Allowance for Obesity Pet Vaccines to Braasch Biotech LLC.on February 26, 2021 at 5:29 am
Braasch Biotech LLC, an emerging biopharmaceutical company pioneering a new field of anti-somatostatin vaccines, today announced a Notice of Allowance was received from the Brazilian Intellectual ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- All Warmind Cell mods - Destiny 2on February 25, 2021 at 11:54 pm
A complete list of all the Warmind Cell mods in Destiny 2 and how to get them. Warmind Cell mods, one of the most powerful armor mods available in Destiny 2, were originally added to the game with ...
- G1 Therapeutics, Inc. (GTHX) Q4 2020 Earnings Call Transcripton February 24, 2021 at 9:00 pm
Q4 2020 Earnings Call Feb 24, 2021, 4:30 p.m. ET Ladies and gentlemen, thank you for standing by, and welcome to G1 Therapeutics Fourth Quarter 2020 Financial Results Conference Call. [Operator ...
- Coin Cell Challenge: Use Coin Cell, Win Prizeson February 23, 2021 at 4:00 pm
The Coin Cell Challenge is your chance to plumb the depths of what can be done with the humble coin cell. This is a contest, and as with the tradition of the Open 7400 Logic Competition and the ...
- Iraq's 'Falcon Cell' leader removed amid accusations of suspicious linkson February 23, 2021 at 3:16 am
The replacing of a top intelligence official whose unit had been responsible for many key arrests signals further efforts to centralize control of Iraq's intelligence services.
- Overengineering The Humble USB Power Bankon February 22, 2021 at 4:00 pm
Most of the DIY power banks we’ve seen in the past have been little more than a simple collection of 18650 cells, so it’s interesting to see one with so much additional functionality packed in.